Molecular Profiling of Acute Myeloid Leukemia in Pakistan: Comprehensive Variant Landscape Revealed by Targeted NGS
International Journal of Molecular Sciences · 28.04.2026 · 27 (9) · 3927
DOI: 10.3390/ijms27093927 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.04.2026. Verfasst von Rafia Mahmood und 9 weiteren Autor:innen. Beteiligte Einrichtung: Armed Forces Institute of Pathology, Rawalpindi 46000, Pakistan. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, High-Throughput Nucleotide Sequencing, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University of Medical Sciences.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) is a heterogeneous malignancy, with clonal complexity and somatic mutations critically influencing prognosis and treatment. While global genomic profiling efforts have revolutionized AML classification and risk stratification, the molecular landscape in Pakistani patients remains underexplored. Our aim is to perform targeted next-generation sequencing (NGS) for somatic mutational profiling of newly diagnosed AML patients in Pakistan. This prospective study was conducted at the Armed Forces Institute of Pathology, Pakistan, from January 2021 to January 2026. Among 104 patients, 204 somatic variants were identified (mean: 1.96 variants/patient), predominantly single-nucleotide variants (49.5%). Missense mutations (38.2%) were most common, with enriched transitions (Ti/Tv: 1.27:1). Frequently mutated genes included TP53 (22.1%), KIT (9.8%), CEBPA (8.8%), and NRAS (5.9%). Cell-signaling genes (30.4%) and tumor suppressor genes (27.0%) were the most affected functional groups. Co-mutation analysis showed clustering led by DNMT3A–IDH1 co-occurrence (ρ ≈ 0.43). DNA-methylation alterations frequently co-occurred with tumor suppressors (OR ≈ 4.6, p = 0.007), transcription factors (OR ≈ 3.9, p = 0.023), and NPM1 (ρ = 0.32). This study provides the first comprehensive genomic map of Pakistani AML patients, revealing unique mutational signatures. The findings lay the groundwork for population-specific precision oncology in low- and middle-income countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Armed Forces Institute of Pathology, Rawalpindi 46000, Pakistan.
- National University of Medical Sciences, Abid Majeed Road, Rawalpindi 46000, Pakistan.
- Islamabad Medical and Dental College, Islamabad 44000, Pakistan.
ORCID-Profile: Rafia Mahmood
Förderung
- National University of Medical Sciences
Zitieren
APA
Mahmood, R., Khan, S. A., Ali, S., Sharif, F., Khurshid, U., Ahmed, D., Shahzad, E., Malik, H. S., Asif, N., & Jahangir, S. (2026). Molecular Profiling of Acute Myeloid Leukemia in Pakistan: Comprehensive Variant Landscape Revealed by Targeted NGS. International Journal of Molecular Sciences, 27(9), 3927. https://doi.org/10.3390/ijms27093927
Vancouver
Mahmood R, Khan SA, Ali S, Sharif F, Khurshid U, Ahmed D, et al. Molecular Profiling of Acute Myeloid Leukemia in Pakistan: Comprehensive Variant Landscape Revealed by Targeted NGS. International Journal of Molecular Sciences. 2026;27(9):3927. doi:10.3390/ijms27093927
BibTeX
@article{Mahmood2026,
author = {Mahmood, Rafia and Khan, Saleem Ahmed and Ali, Sadia and Sharif, Fatima and Khurshid, Umar and Ahmed, Dilshad and Shahzad, Eshal and Malik, Hamid Saeed and Asif, Naghmi and Jahangir, Sidrah},
title = {Molecular Profiling of Acute Myeloid Leukemia in Pakistan: Comprehensive Variant Landscape Revealed by Targeted NGS},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {9},
pages = {3927},
doi = {10.3390/ijms27093927}
}
EUVIMED